Costs and Causes of Oncology Drug Attrition and Insulin-Like Growth Factor-1 Receptor Inhibitors
This cross-sectional study examines the costs generated in clinical trials, using the research and development studies of 16 insulin-like receptor-1 inhibitors in cancer, none of which was approved...
jamanetwork.com